Pathstone Family Office’s Opko Health OPK Stock Holding History

Pathstone Family Office’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-78	Closed	-$1K	–	569
2017 Q1	$1K	Buy	+78	New	+$657	﹤0.01%	498

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

MTWSIF

Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $789M AUM 73.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Pathstone Family Office's OPK Position: Q2 2017 in Review

Pathstone Family Office sold out of Opko Health (OPK) in Q2 2017, closing a stake of 78 shares — an estimated $1K sold.

Pathstone Family Office first reported a position in OPK in Q1 2017 and held it in 1 quarter. The position peaked at $1K in Q1 2017. 232 funds tracked by Wall St. Rank hold OPK as of Q2 2017.

Pathstone Family Office reported no remaining Opko Health position as of Q2 2017 after selling out during the quarter.
Pathstone Family Office sold 78 Opko Health shares in Q2 2017, an estimated $1K.
Pathstone Family Office first reported a position in Opko Health in Q1 2017 and held it in 1 quarter.
Pathstone Family Office's Opko Health position peaked at $1K in Q1 2017.
232 funds tracked by Wall St. Rank held Opko Health as of Q2 2017.

Based on Pathstone Family Office's 13F filing for Q2 2017, filed 11 Aug 2017.